Arena Pharmaceuticals (ARNA) Reports Q4 Loss of $0.60
Tweet Send to a Friend
Arena Pharmaceuticals (Nasdaq: ARNA) reports a Q4 loss of $0.60, 18 cents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
